12/03/2024
5:15 PM | BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
1:44 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
1:27 PM | BioMarin Pharmaceutical (Subject)
Guyer Charles Greg (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
2:01 PM | BioMarin Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/01/2024
3:50 PM | BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/01/2024
3:51 PM | BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:29 PM | BioMarin Pharmaceutical (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G | |
|
09/24/2024
7:31 AM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
4:54 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
11:52 AM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2024
4:02 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2024
4:00 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
10:48 AM | BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
12:14 PM | BioMarin Pharmaceutical (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
07/01/2024
3:19 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
6:28 PM | BioMarin Pharmaceutical (Issuer)
MEIER RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
6:29 PM | BioMarin Pharmaceutical (Issuer)
HERON ELAINE J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
9:18 AM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
5:28 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
9:49 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024
5:18 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
1:22 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024
9:10 AM | BioMarin Pharmaceutical (Subject)
LAWLIS V BRYAN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024
9:18 AM | BioMarin Pharmaceutical (Subject)
Mueller Brian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
9:28 AM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
9:36 AM | BioMarin Pharmaceutical (Subject)
Davis George Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024
4:23 PM | BioMarin Pharmaceutical (Issuer)
Enyedy Mark J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:26 PM | BioMarin Pharmaceutical (Issuer)
HERON ELAINE J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:30 PM | BioMarin Pharmaceutical (Issuer)
Ho Maykin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:33 PM | BioMarin Pharmaceutical (Issuer)
HOMBACH ROBERT J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:34 PM | BioMarin Pharmaceutical (Issuer)
MEIER RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:36 PM | BioMarin Pharmaceutical (Issuer)
PYOTT DAVID E I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:14 PM | BioMarin Pharmaceutical (Issuer)
Countouriotis Athena (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:20 PM | BioMarin Pharmaceutical (Issuer)
Dere Willard H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:06 PM | ANDERSON ELIZABETH M (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:08 PM | BioMarin Pharmaceutical (Issuer)
Bodem Barbara W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:33 PM | BioMarin Pharmaceutical (Issuer)
Hubbard Cristin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/22/2024
3:36 PM | BioMarin Pharmaceutical (Issuer)
Hubbard Cristin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
4:20 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
4:16 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
2:57 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks.
It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives.
But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars.
And here's the good news. Register For The Webinar To Discover |
05/10/2024
9:11 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024
9:54 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
4:58 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:40 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:45 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
4:37 PM | BioMarin Pharmaceutical (Subject)
Davis George Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024
9:49 AM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/26/2024
12:59 PM | BioMarin Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
3:07 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2024
3:11 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
3:21 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
2:07 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
8:49 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/11/2024
8:54 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/09/2024
3:24 PM | BioMarin Pharmaceutical (Filer)
| Form ARS | |
04/09/2024
3:07 PM | BioMarin Pharmaceutical (Filer)
| Form DEF 14A | |
04/09/2024
3:09 PM | BioMarin Pharmaceutical (Filer)
| Form DEFA14A | |
03/20/2024
4:13 PM | BioMarin Pharmaceutical (Issuer)
Slamon Dennis (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:48 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:50 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:53 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:55 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:36 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:40 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:42 PM | BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:46 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
5:54 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
4:32 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
4:35 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
11:04 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
1:41 PM | BioMarin Pharmaceutical (Subject)
FUCHS HENRY J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
11:04 AM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
4:10 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:12 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:14 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:16 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:18 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:05 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
9:35 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
12:34 PM | BioMarin Pharmaceutical (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/13/2024
12:21 PM | BioMarin Pharmaceutical (Subject)
DODGE & COX (Filed by)
| Form SC 13G/A | |
02/12/2024
4:20 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
2:24 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/09/2024
4:46 PM | BioMarin Pharmaceutical (Subject)
Capital Research Global Investors (Filed by)
| Form SC 13G | |
02/09/2024
9:36 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/08/2024
8:46 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024
6:47 PM | BioMarin Pharmaceutical (Issuer)
MEIER RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
3:06 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/11/2024
1:40 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
9:09 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
How Low-Cost Stocks Generate Monthly Income (Ad) Are you ready to transform your investment strategy and generate a steady monthly income?
We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE! 👉 Yes, I Want the Free Report! 👈 |
01/09/2024
10:48 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/28/2023
12:00 PM | BioMarin Pharmaceutical (Issuer)
Countouriotis Athena (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/28/2023
12:03 PM | BioMarin Pharmaceutical (Issuer)
Countouriotis Athena (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
12:11 PM | BioMarin Pharmaceutical (Issuer)
Enyedy Mark J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/28/2023
12:13 PM | BioMarin Pharmaceutical (Issuer)
Enyedy Mark J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
12:15 PM | BioMarin Pharmaceutical (Issuer)
Bodem Barbara W. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/28/2023
12:18 PM | BioMarin Pharmaceutical (Issuer)
Bodem Barbara W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
4:14 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
8:57 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free BMRN Stock Alerts